by Richard Daverman, PhD
July 18, 2012 -- China Health Resource reported it has developed a TCM migraine medication, built around the company’s major product, Dahurian Angelica (DAR) root. According to the company, the product showed an effective rate of 96.5% in clinical observations, though the conditions of the test were not disclosed. China Health Resource produces raw DAR and finished products based on the TCM. More details....
Stock Symbol: (OTCBB: CHRI)
